Adjuvant approach will need confirmation from ongoing phase III trial, says expert

A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug.

If the vaccine is effective in a late-stage trial, it would be “paradigm-shifting,” one expert said.